Skip to content

Autism Access Link for Early Referral and Treatment

Autism Access Link for Early Referral and Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04861740
Acronym
Autism ALERT
Enrollment
148
Registered
2021-04-27
Start date
2020-09-01
Completion date
2024-01-04
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

Autism Spectrum Disorder, Primary Care, Case Management

Brief summary

Autism Access Link for Early Referral and Treatment \[ALERT\], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process. We hypothesize that Autism ALERT will have strong acceptability and high rates of use among primary care providers as well as among diverse low-income patients of children at risk for ASD, and that we will see higher rates of child ASD educational evaluations within six months, and shorter time between referral and ASD treatment, compared with our control.

Detailed description

Though significant research effort has focused on autism spectrum disorder (ASD) screening, less attention has been devoted to optimizing follow-up of children who are subsequently identified as at-risk. Despite increases in ASD screening rates, many children with ASD wait years between when autism is suspected in the primary care setting and when definitive diagnosis and treatment begin. Delayed and missed diagnoses are particularly problematic for low-income and racial/ethnic minority children in the US, who experience higher rates of these adverse outcomes. In this project, we propose to pilot test Autism Access Link to Early Referral and Treatment (Autism ALERT), a statewide monitoring and case management program to accelerate access to ASD diagnosis and treatment among children with suspected ASD the primary care setting. The system will reduce the time between identification of suspected ASD in the primary care setting and establishment of ASD diagnosis and treatment services, by reducing family barriers to care, decreasing primary care provider burdens, and simplifying referral processes. The program will be available to any Oregon child age 12-54 months, regardless of health system or payor type. Autism ALERT will become part of the Help Me Grow national network, which gives it potential for statewide and national spread. In this proposed research, we will pilot test Autism ALERT by comparing it to an existing ASD screening intervention in 6 Oregon primary care practices. Primary goals of this pilot project are to assess feasibility and acceptability of Autism ALERT for primary care providers and families, to test the mechanism of action of Autism ALERT, to pilot test efficacy in reducing time to autism diagnosis and treatment, and to test fidelity of protocol implementation. If successful, this project will be expanded into an implementation/effectiveness R01 in which the program will be tested throughout the state of Oregon. In the long term, this research will result in a sustainable, evidence-based statewide and ultimately national monitoring system children with suspected ASD.

Interventions

Autism Access Link for Early Referral and Treatment \[ALERT\], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process.

Autism screening intervention only.

Sponsors

Boston Medical Center
CollaboratorOTHER
Providence Health & Services
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

We propose a pilot clustered interventional trial with two arms. Clinics in the intervention arm (Screening + Autism ALERT) receive Autism ALERT plus an ASD screening intervention, and clinics in the comparison intervention arm (Screening Only) receive the ASD screening intervention only (START Autism). As this is a pilot trial, primary outcomes of interest are feasibility and acceptability. We will additionally assess mechanism of outcome, preliminary efficacy, and protocol fidelity. Feasibility and acceptability will be assessed in intervention clinics. Mechanism of action and preliminary efficacy will be assessed by comparing intervention to control clinics. Fidelity is assessed in both arms. We will pilot test Autism ALERT in 6 safety-net primary care clinics in Oregon.

Eligibility

Sex/Gender
ALL
Age
12 Months to 54 Months
Healthy volunteers
Yes

Inclusion criteria

child's primary care provider suspects the child has ASD, child is patient at one of the study clinics, child age 12 to 54 months, family speaks English or Spanish, no prior ASD medical diagnosis or ASD diagnostic evaluation

Exclusion criteria

Previous diagnosis of ASD or prior diagnostic evaluation for ASD.

Design outcomes

Primary

MeasureTime frameDescription
Change in provider self-efficacy about autism managementAt enrollment and at study end (~9 months after enrollment)1-item survey measure
Change in Parenting stressAt enrollment and 6 months after enrollmentQuestionnaire on Resources and stress - Short Form
Change in Family EmpowermentAt enrollment and 6 months after enrollmentParent Survey - Family Empowerment Scale, Family Subscale
Change in Family Centered and Coordinated CareAt enrollment and 6 months after enrollmentParent Survey - Items from National Survey of Children's Health, Medical Home item set
Family Satisfaction with Program6 months after enrollment - Autism ALERT + Screening arm onlyParent Survey items - Satisfaction with Interpersonal Relationship with Navigator (PSN-I), Client Satisfaction Questionnaire - 8
% referred to program who complete an ASD educational evaluation within 6 months6 months after enrollmentAdministrative data - Oregon Early Intervention/Early Childhood Special Ed (EI/ECSE) database
Time from EI/ECSE referral to ASD treatment in EI/ECSE, among children with ASDmeasured 9 months after enrollmentAdministrative data - Oregon EI/ECSE database
Family self-reported ASD knowledgeAt enrollment and 9 months after enrollment5-item survey measure
Change in satisfaction with Care Coordination in general and for autism in particularAt enrollment and study end (~9 months after enrollment)2 separate provider survey measures
Change in Parent stressAt enrollment and 6 months after enrollmentParent Survey - Parenting Stress Index

Secondary

MeasureTime frameDescription
Time from EI/ECSE referral to evaluation among children with ASDmeasured 9 months after enrollmentAdministrative data - Oregon EI/ECSE database
Age of EI/ECSE educational determination, among children with ASDmeasured 9 months after enrollmentAdministrative data - Oregon EI/ECSE database
% with ASD determination receiving ASD services 6 months after enrollmentmeasured 9 months after enrollmentAdministrative data - Oregon EI/ECSE database
monthly service hours among children with ASD 6 months after enrollmentmeasured 9 months after enrollmentAdministrative data - Oregon EI/ECSE database
age of ASD medical diagnosis among children on MedicaidMeasured 1 year after study enrollmentAdministrative data - Medicaid claims
% with ASD medical diagnosis receiving ASD therapy 6 months after enrollment, among children on MedicaidMeasured 1 year after study enrollmentAdministrative data - Medicaid claims
Change in provider autism paperwork burdenAt enrollment and at study end (~9 months after enrollment)Provider survey item

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026